Immix Biopharma (IMMX) Proxy Filing summary

Executive summary

• Annual Meeting of Stockholders scheduled for June 20, 2025, at the company's Los Angeles office.

• Supplement filed to include required Inline XBRL tagging and new disclosures on equity grant and clawback policies.

Board of directors and corporate governance

• Insider Trading Policy governs securities transactions by directors, officers, employees, and consultants, promoting compliance with laws and listing standards.

Executive compensation and say-on-pay

• Compensation Committee reviews and approves annual equity award grants, considering the timing of material nonpublic information.

• No options were granted to named executive officers during sensitive periods around material disclosures in 2024.

• Clawback Policy adopted effective October 2, 2023, mandates recovery of erroneously awarded incentive compensation from current and former executive officers if an accounting restatement is required.

• Clawback applies regardless of officer misconduct and covers compensation received within three fiscal years before a restatement.